Nectin Therapeutics Announces $5.4 Million Investment from Cancer Focus Fund to Support Phase 1 Study of First-in-Class Anti-PVR Targeted Immunotherapy

Warburg Pincus Co-Leads Latest Funding Round in Israel’s MDClone

Precision immunology player bags $110M to fund its work on ‘disease signature’ tests

Omada Health Valued at $1 Billion-Plus in Fidelity-Led Round

Investors expect to pour more funds into digital health, survey shows

12 על 12: הדמויות המשפיעות בענף ההלת’טק

Adicet unveils early responses for off-the-shelf drug leveraging rare T cells. Will durability hold up?

5 minutes with Abigail Hirsch, Co-founder of Lin Health

How AI interfaces can help therapists provide better behavioral health care

Eleos Health raises $8M for behavioral health focused AI voice tech

Rising aMoon and its growing portfolio at the healthcare-tech interface

AI For Population Health And Medical Imaging Gets A Boost With $230 Million Acquisitions

Sophia Genetics Raises $234M in IPO, Eyes Additional Partnerships

Small activating RNAs lead the charge to turn up gene expression

MOBILion Systems racks up another $60M to bring faster, smarter mass spectrometry to biopharma

Eli Lilly adds a $15M equity sweetener for its platform partner in saRNA

Diets Engineered to Work With Your Microbiome Are Latest Startup Craze

An Israeli biotech is looking to make its name in the jam-packed CD47 space. Is bifunctionality the answer?

KAHR Announces $46.5 Million Financing to Advance its Multifunctional Immunotherapeutic Pipeline

MDClone Awarded as Technology Pioneer by World Economic Forum

Ibex Medical Analytics granted ‘Breakthrough Device Designation’ by the FDA, fast-tracking its approval

Lilly enlists a long-incubating RNA upstart in new $1.25B partnership

New name, new board, new focus: AltruBio relaunches with $63M series A

The People in This Medical Research Are Fake. The Innovations Are Real.

Scipher Medicine Announces $82 Million Financing

Ibex Medical Analytics raises $38M for its AI-powered cancer diagnostic platform

Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement

Michael Ehlers is betting $40M that an AI outfit has figured out how to beat the blockbuster IL-2 challenge

Will the quickly developed vaccines deliver Covid-19 a knockout blow?

Israeli Healthtech Venture Fund Sees Industry ‘Revolution’